Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
information on the Center's activities and researchers, please see DARK – University of Copenhagen (ku.dk) Principal supervisor isProfessorJens Hjorth, DARK, Niels Bohr Institute, E-mail: [email protected] The PhD
-
5 Mar 2024 Job Information Organisation/Company University of Copenhagen Department Department of Plant and Environmental Sciences Research Field Biological sciences » Biology Researcher Profile
-
. What we offer We offer a unique research experience in an interdisciplinary research project, in collaboration with the University of Copenhagen and an industry partner and combining state-of-the-art
-
of RIBOTACs. The project is a collaboration with research groups at the Universities of Copenhagen and Bergen. The position is a joint appointment within the research group in Chemical Biology and Medicinal
-
services. Conduct system demonstrations in real-world neural network applications such as natural language processing tasks with our collaborators in the University of Copenhagen. Disseminating your research
-
with SODAS at the University of Copenhagen. PhD scholarship in Linearized floating wind farm modelling - DTU Wind Denmark Posted on 04/29/2024 Are you a curious, self-driven individual with a strong
-
at the University of Copenhagen. Two postdoc positions in Cyber-Physical Systems - DTU Compute Denmark Posted on 03/20/2024 Join our team as a Postdoc in Cyber-Physical Systems at DTU Compute, focusing on cutting
-
, but also associated with SODAS at the University of Copenhagen. The Cognitive Systems Section at DTU: Advanced data analysis is increasingly a determinant for productivity and personal quality of life
-
Compute, but also associated with SODAS at the University of Copenhagen. The Cognitive Systems Section at DTU: Advanced data analysis is increasingly a determinant for productivity and personal quality
-
), The Novo Nordisk Foundation Center for Stem Cell Medicine (renew) at University of Copenhagen, and Bioneer A/S that aims at developing new in vitro disease models and cell therapies using human induced